Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression

Clinical and Experimental Metastasis

Volumn 18, Issue 5, 2000, Pages 429-438

  Shaker, Mohammad R ^a   Yang, Guang ^a   Timme, Terry L ^a   Park, Sang H ^a   Kadmon, Dov ^a   Ren, Chengzhen ^a   Ji, Xiaorong ^a   Lee, Hon Man ^a   Sehgal, Inder ^a   Anzano, Mario ^b   Sporn, Michael B ^c   Thompson, Timothy C ^a,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bone metastasis; Chemoprevention; Prostate cancer; Retinoids

Indexed keywords

FENRETINIDE; RETINOID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE METASTASIS; CANCER GROWTH; CANCER SURVIVAL; CELL GROWTH; CONTROLLED STUDY; DIETARY INTAKE; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROSTATE CANCER; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CELL DIVISION; DIET; DISEASE MODELS, ANIMAL; FENRETINIDE; MALE; MICE; PROSTATIC NEOPLASMS; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034955529     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010905309570     Document Type: Article

References (22)

1. Cancer statistics, 2000
2. Allelic loss in locally metastatic, multi- sampled prostate cancer
3. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization
4. Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer
5. The role of p53 in prostate cancer progression
6. Mouse prostate reconstitution model system: A series of in vivo and in vitro models for benign and malignant disease
7. Prognostic significance of positive surgical margins in radical prostatectomy specimens
8. Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcome
9. In situ gene therapy for prostate cancer
10. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids)
11. Inhibition of 1,2-dimethylbenz (a) anthracene induced mammary carcinogenesis by retinyl acetate
12. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen
13. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl) retinamide
14. The inhibitory effect of 4-hydroxyphenyl retinamide (4-HPR) on metastasis of prostate adenocarcinoma III cells in Lobund-Wistar rats
15. Dietary fenretinide, a synthetic retinoid decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system
16. Retinoic acid negatively regulates b4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma cell line
17. Chemoprevention in prostate cancer
18. Rapid allelotype analysis of p53 knockout mice
19. Multi-stage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
20. Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancer
21. Reduced lysyl oxidase mRNA levels in experimental and human prostate cancer